UNITED THERAPEUTICS Corp·4

Dec 19, 4:31 PM ET

Thompson Tommy G 4

4 · UNITED THERAPEUTICS Corp · Filed Dec 19, 2025

Insider Transaction Report

Form 4
Period: 2025-12-18
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-18$101.80/sh+910$92,6389,390 total
  • Sale

    Common Stock

    2025-12-18$500.59/sh910$455,5338,480 total
  • Exercise/Conversion

    Stock Option

    2025-12-189104,000 total
    Exercise: $101.80From: 2017-06-21Exp: 2026-06-21Common Stock (910 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,200
  • Common Stock

    (indirect: By LLC)
    5,800
Footnotes (2)
  • [F1]Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
  • [F2]This transaction was executed in multiple trades at prices ranging from $500.38 to $500.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT